A clinical trial carried out in Mali and the United States of America has shown that a new Ebola vaccine developed under the auspices of the World Health Organisation has promises. The study report published in the Lancet Infectious Diseases Journal says the vaccine protects people who are close to Ebola patients such as health workers and relatives and thus can break the transmission chain and hence curtail the spread of the disease.
The study was conducted by the University of Maryland, United States of America.
Guinea where the Ebola outbreak in West Africa started in December 2015 is now Ebola free; it was declared so by the World Health Organisation (WHO) on Tuesday 29/12/15.
During the period December 2013 to December 2015, the country lost about 2,500 persons less than Liberia and Sierra Leone.
Sierra Leone became Ebola free earlier.
The announcement was made by Dr. Moeti, the regional director of WHO for Africa